The associations between ARSI expression and clinicopathological features, such as tumor size, lymph node metastasis, and advanced TNM stage, underscore its relevance to PTC aggressiveness and disease progression. The gene discussed is ARSI; the disease is metastatic malignant neoplasm in the lymph nodes.